This study examined the effectiveness of pirfenidone (PFD) in treating pulmonary fibrosis in patients who suffered from acute paraquat poisoning, comparing those treated with PFD to those who were not.
Results showed that the PFD group had a significantly higher effective treatment rate and improved pulmonary function, as indicated by various medical metrics, compared to the NO-PFD group.
The study concluded that PFD is a safe and effective option for enhancing treatment outcomes in these patients, improving both lung function and survival rates without substantial liver or kidney damage.